• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original PMA or panel track supplement and may not represent the most recent labeling.
 
DeviceCELT ACD VASCULAR CLOSURE DEVICE
Generic NameDevice, hemostasis, vascular
ApplicantVasorum, Ltd.
2012 Orchard Ave.
Citywest Business Campus
Dublin 24
PMA NumberP150006
Date Received02/03/2015
Decision Date07/20/2016
Product Code MGB 
Docket Number 16m-2185
Notice Date 07/25/2016
Advisory Committee Cardiovascular
Clinical TrialsNCT01600482
Expedited Review Granted? No
Combination ProductNo
Predetermined Change Control Plan AuthorizedNo
Approval Order Statement  
Approval for the Celt ACD Vascular Closure Device. This device is indicated for the percutaneous closure of common femoral artery puncture sites while reducing time-to-hemostasis in patients who have undergone diagnostic or interventional intra-arterial catheterization procedures where either 5F or 6F introducer sheaths have been used.
Approval OrderApproval Order
SummarySummary of Safety and Effectiveness
LabelingLabeling
Supplements:  S001 S006 S007 S004 S009 
-
-